Steroid Use in ABO-Incompatible Kidney Transplants: Withdrawal vs Maintenance
Annals of Transplantation · 2025
DOI: 10.12659/aot.947747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Transplantation, 2025. Verfasst von Dong Hui Shin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, South Korea. Hauptthemen laut MEDLINE: Kidney Transplantation, ABO Blood-Group System, Graft Rejection, Immunosuppressive Agents. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND The incidence of ABO-incompatible (ABO-i) kidney transplantation (KT) is increasing. Furthermore, it has a higher early mortality rate than ABO-compatible (ABO-c) KT, which is largely attributed to the extensive use of immunosuppressive agents. While steroid use in patients with ABO-c KT is being reduced, this effort is less prevalent in patients with ABO-i KT. Therefore, our study investigated the specific impact of steroid withdrawal on graft survival in patients with ABO-i KT. MATERIAL AND METHODS This study evaluated 33 patients who underwent ABO-i KT. The primary outcome was biopsy-proven acute rejection. The secondary outcomes were graft function, infection, new-onset diabetes mellitus after transplantation (NODAT), and delayed graft function. RESULTS In an average follow-up period of 57.0±23.7 months, the cumulative probabilities of biopsy-proven rejection at 3 years post-transplantation were 30.8% in the steroid maintenance group and 40.0% in the steroid withdrawal group, with no significant difference (hazard ratio, 1.11; 95% confidence interval 0.32-3.9; P=0.648). Graft function was similar between the 2 groups. Steroid withdrawal did not affect the rates of infection, NODAT, osteoporosis, cardiovascular disease, BK virus viremia, or cytomegalovirus viremia. CONCLUSIONS Steroid withdrawal did not differ from steroid maintenance in the rate of rejection or graft function due to any cause.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Yonsei University Wonju College of Medicine, Wonju, South Korea.
- David Geffen School of Medicine at UCLA, University of California, Los Angeles, CA, USA.
- Department of Statistics, Yonsei University Wonju College of Medicine, Wonju, South Korea.
- Division of Transplant Surgery, Department of Surgery, Severance Hospital, Seoul, South Korea.
ORCID-Profile: Dong Hui Shin, Keunryeol Park, Deok Gie Kim, Jun Young Lee
Zitieren
APA
Shin, D. H., Kim, J. T., Kim, S. H., Park, K., Kim, D. G., & Lee, J. Y. (2025). Steroid Use in ABO-Incompatible Kidney Transplants: Withdrawal vs Maintenance. Annals of Transplantation. https://doi.org/10.12659/aot.947747
Vancouver
Shin DH, Kim JT, Kim SH, Park K, Kim DG, Lee JY. Steroid Use in ABO-Incompatible Kidney Transplants: Withdrawal vs Maintenance. Annals of Transplantation. 2025. doi:10.12659/aot.947747
BibTeX
@article{Shin2025,
author = {Shin, Dong Hui and Kim, Ji Teak and Kim, Sung Hwa and Park, Keunryeol and Kim, Deok Gie and Lee, Jun Young},
title = {Steroid Use in ABO-Incompatible Kidney Transplants: Withdrawal vs Maintenance},
journal = {Annals of Transplantation},
year = {2025},
doi = {10.12659/aot.947747}
}
EUVIMED